JP2002500872A - 免疫エフェクター細胞ハイブリッド - Google Patents

免疫エフェクター細胞ハイブリッド

Info

Publication number
JP2002500872A
JP2002500872A JP2000528295A JP2000528295A JP2002500872A JP 2002500872 A JP2002500872 A JP 2002500872A JP 2000528295 A JP2000528295 A JP 2000528295A JP 2000528295 A JP2000528295 A JP 2000528295A JP 2002500872 A JP2002500872 A JP 2002500872A
Authority
JP
Japan
Prior art keywords
cells
antigen
immune effector
population
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000528295A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002500872A5 (enExample
Inventor
ロバーツ，ブルース・エル
ニコレット，チャールズ・エイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of JP2002500872A publication Critical patent/JP2002500872A/ja
Publication of JP2002500872A5 publication Critical patent/JP2002500872A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4256—Tumor associated carbohydrates
    • A61K40/4257—Mucins, e.g. MUC-1

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2000528295A 1998-01-26 1999-01-25 免疫エフェクター細胞ハイブリッド Pending JP2002500872A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8835798P 1998-01-26 1998-01-26
US60/088,357 1998-01-26
US8004198P 1998-03-31 1998-03-31
US60/080,041 1998-03-31
PCT/US1999/001464 WO1999037313A1 (en) 1998-01-26 1999-01-25 Immune effector cell hybrids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009102653A Division JP2009195235A (ja) 1998-01-26 2009-04-21 免疫エフェクター細胞ハイブリッド

Publications (2)

Publication Number Publication Date
JP2002500872A true JP2002500872A (ja) 2002-01-15
JP2002500872A5 JP2002500872A5 (enExample) 2009-06-18

Family

ID=26762993

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000528295A Pending JP2002500872A (ja) 1998-01-26 1999-01-25 免疫エフェクター細胞ハイブリッド
JP2009102653A Withdrawn JP2009195235A (ja) 1998-01-26 2009-04-21 免疫エフェクター細胞ハイブリッド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009102653A Withdrawn JP2009195235A (ja) 1998-01-26 2009-04-21 免疫エフェクター細胞ハイブリッド

Country Status (5)

Country Link
EP (1) EP1071436A4 (enExample)
JP (2) JP2002500872A (enExample)
AU (1) AU2339299A (enExample)
CA (1) CA2318987A1 (enExample)
WO (1) WO1999037313A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142974A1 (en) * 1998-09-11 2002-10-03 Leonard D. Kohn Immune activation by double-stranded polynucleotides
EP1168924A4 (en) * 1999-03-31 2002-09-04 Univ Pittsburgh DERIVATIVED IMMUNOGENES IN VITRO INDUCTION OF ANTIQUE-SPECIFIC T-CELLS USING DENDRITIC CELL-TUMOR CELL OR DENDRITIC CELL-VIRAL CELL
DE60226853D1 (de) * 2001-02-20 2008-07-10 Ortho Mcneil Pharm Inc Zelltherapieverfahren für die behandlung von tumoren
US20040071671A1 (en) 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
FR2828934B1 (fr) * 2001-08-27 2004-08-13 Inst Nat Sante Rech Med Test de l'immunite cellulaire par des peptides fixes sur support solide
AU2003275767A1 (en) * 2002-11-07 2004-06-07 Johnson & Johnson Research Pty Limited A means of producing and utilising a population of disease specific cytotoxic T-lymphocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002156A1 (en) * 1992-07-16 1994-02-03 The Board Of Trustees Of Leland Stanford Junior University Methods for using dendritic cells to activate t cells
DE69839215T2 (de) * 1997-04-15 2009-03-19 Dana-Farber Cancer Institute, Inc., Boston Dendritische zellhybride

Also Published As

Publication number Publication date
AU2339299A (en) 1999-08-09
EP1071436A4 (en) 2003-08-27
CA2318987A1 (en) 1999-07-29
EP1071436A1 (en) 2001-01-31
WO1999037313A1 (en) 1999-07-29
JP2009195235A (ja) 2009-09-03

Similar Documents

Publication Publication Date Title
EP1068296B1 (en) Compositions for eliciting an immune response to a telomerase antigen
JP6230208B2 (ja) 樹状細胞／腫瘍細胞融合物および抗ｃｄ３／ｃｄ２８を使用する抗腫瘍免疫の刺激
US20020018766A1 (en) Genes differentially expressed in cancer cells to design cancer vaccines
JP2011504101A5 (enExample)
US7601342B2 (en) Cell fusions and methods of making and using the same
US20020041868A1 (en) Cell fusions and methods of making and using the same
JP2009195235A (ja) 免疫エフェクター細胞ハイブリッド
US9597384B2 (en) Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells
US20020006397A1 (en) In VIVO loading of MHC
JP2002506633A (ja) Ｔ細胞応答を誘発するための遺伝子に基づくワクチンの組成物および使用法
AU3102999A (en) Induction of immunity against tumor self-antigens
AU2007231612B2 (en) Immune effector cell hybrids
AU2003271378B2 (en) Immune effector cell hybrids
EP1063891A2 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
US20020065241A1 (en) Antigenic peptide concatomers
AU2007201829A1 (en) Immune effector cell hybrids
JP2002500891A (ja) 抗原特異細胞、これらの細胞の生成方法及びその使用法
CA2344768A1 (en) Hu antigen-derived peptides and uses thereof
CA2387391A1 (en) Hu antigen-derived peptides and uses thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081021

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090120

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090127

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090220

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090319

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090327

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20090421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20090421

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100304